OneStep Raises $36M in Series B to Revolutionize Health Analysis

OneStep's co-founders: Chief Scientific Officer Yuval Naveh, CTO Shahar Davidson, CEO Tomer Shussman

Israeli health-tech startup OneStep has secured $36 million in Series B funding led by Team8 and Vintage Investment Partners, with additional backing from previous investors Aleph, 10D, and LionBird, bringing total funding to $48 million. The company’s innovative technology turns smartphones into clinical-grade motion analysis tools, enabling healthcare providers to assess, treat, and monitor patients’ mobility remotely.

OneStep’s FDA-approved technology simplifies gait analysis—a crucial indicator of health—for use in hospitals, physical therapy clinics, nursing homes, and beyond. By expanding its capabilities to cognitive monitoring, the company now supports patients with conditions like Alzheimer's and Parkinson's.

Traditional gait analysis usually involves costly lab setups and scheduled appointments, limiting it to single-use events. In contrast, OneStep's tool can perform gait measurements in just five seconds through a smartphone, allowing users to receive instant, continuous assessments simply by taking a few steps with their phone in their pocket. The platform tracks 40 metrics, such as step length, leg balance, and joint motion, for a comprehensive health profile.

Founded in 2019 by Tomer Shussman, Yuval Naveh, Shahar Davidson, and Amir Milo—all alumni of the IDF’s Talpiot program—the company is headquartered in Tel Aviv with additional staff in the U.S. "Our goal is to make gait measurement a routine check, like weighing yourself," Shussman says, noting the company’s success in helping rehab patients recover faster and reducing elderly falls by 20%. OneStep envisions a future where 1 in 4 people regularly monitor their walking.

Source: Sophie Shulman / CTech